Skip to main content
SpringerLink
Log in

Treatment of Deep Vein Thrombosis (DVT) with Low Molecular Weight Heparins (LMWH)

  • Chapter
Heparin and Related Polysaccharides

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 313))

Abstract

The medical treatment of established deep venous thrombosis (DVT) includes thrombolytic agents and/or anticoagulants (heparins followed by oral antivitamin K agents).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abildgaard, U., Norrheim, L., Larsen A.E., Nesvold, A., Sandset, P.M., Odegaard, O.R., 1990. Monitoring therapy with LMW Heparin; a comparison of three chromogenic substrate assays and the Heptest clotting assay. Haemostasis 20:193–203.

    PubMed  CAS  Google Scholar 

  • Aiach, M. 1991. Should deep venous thrombosis treatment with low molecular weight heparin (Fragmin®) be monitored or not? Results of a randomized comparative multicentric french study. Thromb. Haemostas. 65:754, abst. 307.

    Google Scholar 

  • Albada, J., Nieuwenhuis, H.K. and Sixma, J.J., 1989. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin®): results of a double blind randomized study. Circulation. 80:935–940.

    Article  PubMed  CAS  Google Scholar 

  • Anonyme, 1989. Traitement des thromboses veineuses profondes constituées. Etude comparative d’un fragment d’héparine de bas poids moléculaire (Fragmine®) administrée par voie sous-cutanée, et de l’héparine standard administrée par voie intraveineuse continue. Etude multicentrique. Rev. Med. Interne. 10:375-381.

    Google Scholar 

  • Barritt, D.W., and Jordan, S.G., 1960. Anticoagulant drugs in the treatment of pulmonary embolism. Lancet 1:1309.

    Article  PubMed  CAS  Google Scholar 

  • Bratt, G., Tornebohm, E., Granqvist, S., Aberg, W., Lockner, B., 1985. A comparison between low molecular weight heparin (Kabi 2165) and standard heparin in the intravenous treatment of deep venous thrombosis. Thromb. Haemostas. 54:813–817.

    CAS  Google Scholar 

  • Bratt, G., Aberg, W., Johansson, M., Törnebohm, E., Granqvist, S., Lockner, D., 1990. Two daily subcutaneous injections of Fragmin as compared with intravenous standard heparin in the treatment of deep vein thrombosis (DVT). Thromb. Haemostas. 64:506–510.

    CAS  Google Scholar 

  • Carter, C.J., Kelton, J.G., Hirsh, J., Cerskus, A., Santos, A.V., Gent, M., 1982. The relationship between the haemorrhagic properties of low molecular weight heparin in rabbits. Blood 59:1239–1245.

    PubMed  CAS  Google Scholar 

  • Duroux, P., 1991. A randomised trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenous unfractionated heparin in the treatment of deep vein thrombosis. A collaborative European Multicentre Study. Thromb. Haemostas. 65:251–256.

    Google Scholar 

  • Elias, A., Lecorff, G., Bouvier, J.L., Aillaud, M.F., Juhan-Vague, I., Toulemonde, F., Serradimigni, A., 1986. Treatment of deep vein thrombosis by a very low molecular weight heparin fragment (CY 222): a dose range study. Thromb. Res, suppl. VI, 82, abst. 162.

    Google Scholar 

  • Faivre, R., Neuhart, Y., Kieffer, Y., Apfel, F., Magnin, D., Didier, D., Toulemonde, F., Bassand, J.P., Maurat, J.P., 1988. Un nouveau traitement des thromboses veineuses profondes; les fractions d’héparine de bas poids moléculaire. Etude randomisée. Presse Med. 17:197–200.

    PubMed  CAS  Google Scholar 

  • Handeland, G.F., Abildgaard, U., Holm, H.A., Arnesen, K.E., 1990. Dose adjusted heparin treatment of deep venous thrombosis; a comparison of unfractionated and low molecular weight heparin. Eur. J. Clin. Pharmacol. 39:107–112.

    Article  PubMed  CAS  Google Scholar 

  • Hommes, D.W., Bura, A., Mazzolat, L., Büller, H.R., ten Cate, J.W., 1991. Subcutaneous heparin compared to continuous intravenous heparin administration in the initial treatment of deep vein thrombosis: A systemic overview and meta-analysis. Thromb. Haemostas. 65:753, abst. 305.

    Google Scholar 

  • Huet, Y., Gouault-Heilmann, M., Contant, G., Brun-Buisson, C., 1987. Treatment of acute pulmonary embolism by a low molecular weight heparin fraction. A preliminary study. Intensive Care Med. 13:126–130.

    Article  PubMed  CAS  Google Scholar 

  • Hull, R.D., Raskob, G.E., Hirsh, J., Jay, R.M., Leclerc, J.R., Geerts, W.H., Rosenblum, D., Sackett, D.L., Anderson, C., Harrison, L., Gent, M., 1986. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N. Engl. J. Med. 315:1109–1114.

    Article  PubMed  CAS  Google Scholar 

  • Hull, R.D., Raskob, G.E., Pineo, G.F., Green D., Trowbridge, A.A., Elliott, C.G. et al. 1991. A randomized double-blind trial of low-molecular weight heparin in the initial treatment of proximal-vein thrombosis. Thromb. Haemostas. 65:872. abst. 620.

    Google Scholar 

  • Janvier, G., Dugrais, G., Winnock, S., Vergnes, C., Boisseau, M., Broussin, J., Serise, J.M., Boissieras, P., Videau, J., Toulemonde, F. 1987. Le CY 222, héparine de très bas poids moléculaire dans le traitement curatif des thromboses veineuses profondes. A propos de 95 observations. Résultats cliniques et phlébographiques. J. Mal. Vascul. 12:141–144.

    Google Scholar 

  • Lane, D.A., Flynn, A., Ireland, H., Anastassiades, E., Curtis, J.R., 1986. On the evaluation of heparin and low molecular weight heparin in haemodialysis for chronic renal failure. Haemostasis 16(suppl. 2):38–47.

    PubMed  Google Scholar 

  • Lopaciuk, S., 1991. Activity of Fraxiparine® in the treatment of DVT. ISH-Xlth Meeting, Basel, August 31, Fraxiparine in the nineties”.

    Google Scholar 

  • Pini, M., Pattacini, C., Quintavalla, R., Poli, T., Megha, A., Tagliaferri, A., Manotti, C., Dettori, A.G., 1990. Subcutaneous vs intravenous heparin in the treatment of deep venous thrombosis. A randomized Clinical Trial. Thromb. Haemostas. 64:222–226.

    CAS  Google Scholar 

  • Prandoni, P., Vigo, M., Cattelan, A.M., Ruol, A. 1990. Treatment of deep venous thrombosis by fixed doses of a low-molecular weight heparin (CY 216). Haemostasis 20(suppl. l):220–223.

    PubMed  Google Scholar 

  • Prandoni, P., 1991. Fixed dose LMW Heparin (CY 216) as compared with adjusted dose intravenous heparin in the initial treatment of symptomatic proximal venous thrombosis. Thromb. Haemostas. 65:872, abst. 618.

    Google Scholar 

  • Rogers, L.Q., Lutcher, C.L., 1990. Streptokinase therapy for deep vein thrombosis: a comprehensive review of the English literature. Am. J. Med. 88:389–395.

    Article  PubMed  CAS  Google Scholar 

  • Samama, M, Desnoyers, P., 1991. Low-molecular-weight heparins and related glycosaminoglycans in the prophylaxis and treatment of venous thromboembolism, in: “Recent Advances in Blood Coagulation”, vol. 5. L. Poller, ed. Churchill Livingstone, Edinburgh. pp 177–222.

    Google Scholar 

  • Siegbahn, A., Shams, Y-Hassan, Roberg, J., Bylund, H., Neerstrand, H.S., Ostergaard, P., Hedner, U., 1989. Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-NOVO. Thromb. Res. 55:767–778.

    Article  PubMed  CAS  Google Scholar 

  • Simonneau, G. 1991. Subcutaneous fixed dose of Enoxaparine (E) versus intravenous adjusted dose of unfractionated heparin (UH) in the treatment of deep venous thrombosis (DVT). TVPENOX Group Study. Thromb. Haemostas. 65: 754, abst. 306.

    Google Scholar 

  • Turpie, A.G.G., Thrombolysis in deep vein thrombosis, in: “Thrombolysis in cardiovascular disease“ Julian, D.G., Kübier, W., Norris, R.M., Swan, H.J., Collen, D., Verstraete, M. eds., Marcel Dekker, Inc. New-York-Basel (1989) p.397–408.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratoire Central d’Hématologie, Hôtel-Dieu, 75181, Paris cedex 04, France

    Michel-Meyer Samama

Authors
  1. Michel-Meyer Samama
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Charing Cross and Westminster Medical School, London, UK

    David A. Lane

  2. The Swedish University of Agricultural Sciences, Uppsala, Sweden

    Ingemar Björk

  3. Uppsala University, Uppsala, Sweden

    Ulf Lindahl

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Samama, MM. (1992). Treatment of Deep Vein Thrombosis (DVT) with Low Molecular Weight Heparins (LMWH). In: Lane, D.A., Björk, I., Lindahl, U. (eds) Heparin and Related Polysaccharides. Advances in Experimental Medicine and Biology, vol 313. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-2444-5_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-2444-5_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-2446-9

  • Online ISBN: 978-1-4899-2444-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation